In addition, using an unbiased platelet proteome analysis, we found that (2) the total amount of one part of this integrin complex, ITGA2B, was decreased in all COVID-19 patients compared to healthy controls, and in non-survivors the decrease was even stronger after 4–5 days. Here, ITGA2B is linked to COVID-19.